Yüklüyor......
SHP2: a new target for pro-senescence cancer therapies
Cellular senescence is a response to stress that disables cell proliferation and orchestrates an inflammatory process that eliminates damaged cells. The first pro-senescence drugs for cancer treatment are now a clinical reality, but still few targets have been identified whose inactivation results i...
Kaydedildi:
| Yayımlandı: | EMBO J |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BlackWell Publishing Ltd
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4474521/ https://ncbi.nlm.nih.gov/pubmed/25916826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/embj.201591616 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|